liver failure - Nursing Case Study
Pathophysiology
• Primary mechanism: Hepatocyte injury leads to decreased liver function, disrupting the metabolism of toxins, drugs, and endogenous waste products, resulting in their accumulation and systemic toxicity.
• Secondary mechanism: Impaired protein synthesis, particularly of albumin and coagulation factors, causes hypoalbuminemia, leading to edema and ascites, and coagulopathy, increasing bleeding risk.
• Key complication: Portal hypertension develops due to increased resistance within the liver, causing varices and contributing to splenomegaly and ascites, which further complicate patient management.
Patient Profile
Demographics:
52, male, construction worker
History:
• Key past medical history: Chronic alcohol use, Hepatitis C infection, hypertension
• Current medications: Lisinopril, Furosemide, Lactulose
• Allergies: None
Current Presentation:
• Chief complaint: Increasing abdominal pain and swelling
• Key symptoms: Jaundice, ascites, fatigue, nausea, confusion, easy bruising
• Vital signs: Blood pressure 98/60 mmHg, heart rate 110 bpm, respiratory rate 22 breaths per minute, temperature 37.8°C, oxygen saturation 94% on room air
Section 1
As the healthcare team continues to monitor the 52-year-old male patient with liver failure, new diagnostic results reveal a worsening scenario. Laboratory tests show elevated liver enzymes, with AST at 220 U/L and ALT at 190 U/L, indicating ongoing hepatocellular damage. Bilirubin levels are significantly elevated at 6.3 mg/dL, correlating with the patient's jaundice. The patient's INR is 2.1, confirming impaired coagulation, which raises the risk for spontaneous bleeding. His albumin level has decreased to 2.4 g/dL, exacerbating his ascites and peripheral edema. Additionally, a complete blood count indicates thrombocytopenia with a platelet count of 95,000/mm³, further complicating the bleeding risk.
A Doppler ultrasound of the abdomen was performed to assess the severity of portal hypertension. The results show significant splenomegaly and the presence of esophageal varices, posing a potential for life-threatening hemorrhage. The ultrasound also confirms large amounts of ascitic fluid, which explains the patient's increased abdominal pain and swelling. The combination of these findings suggests that the patient's liver disease has progressed to a more advanced stage, necessitating careful monitoring and potential adjustment of therapeutic strategies.
These diagnostic results provide crucial insights into the patient's current condition, guiding the healthcare team in refining the management plan. The focus will shift towards preventing complications such as variceal bleeding and further deterioration of liver function. This may involve optimizing the patient's diuretic regimen, considering beta-blockers to reduce portal pressure, and evaluating the need for endoscopic intervention to manage varices. Clinicians must prioritize maintaining hemodynamic stability and addressing any signs of hepatic encephalopathy, given the patient's ongoing confusion. These steps are critical in improving the patient's quality of life while preparing for potential future interventions, such as liver transplantation evaluation.
Section 2
As the patient's condition continues to be closely monitored, the healthcare team observes a change in his status, indicating the development of new complications. Over the past 24 hours, the patient has exhibited increased confusion and disorientation, raising concerns about the onset of hepatic encephalopathy. His family reports that he is more lethargic and has difficulty staying awake during conversations. Asterixis is noted during the physical examination, further suggesting neurocognitive impairment associated with worsening liver function. Vital signs reveal a blood pressure of 100/65 mmHg, heart rate of 95 bpm, respiratory rate of 18 breaths per minute, and oxygen saturation of 94% on room air. The patient’s temperature remains normal.
In response to these findings, the healthcare team decides to initiate treatment with lactulose to help reduce ammonia levels, which are currently elevated at 95 µmol/L. This intervention aims to decrease the encephalopathy symptoms and improve cognitive function. Meanwhile, the patient’s diuretic therapy is adjusted to better manage the ascites and peripheral edema, with careful monitoring of electrolytes to prevent any imbalance. The patient's complete blood count reveals a further decrease in platelet count to 80,000/mm³, necessitating heightened vigilance for bleeding risks, especially given the presence of esophageal varices.
This change in the patient's status prompts the healthcare team to reassess the management plan and consider additional interventions to stabilize his condition. The possibility of endoscopic evaluation and banding of varices is discussed, alongside the potential need for more intensive monitoring in a higher-acuity setting. These steps are essential to prevent life-threatening complications while ensuring the patient remains a viable candidate for future liver transplantation. The team remains focused on improving the patient's quality of life, addressing immediate complications, and exploring long-term treatment options.
Section 3
As the patient continues to receive treatment, the healthcare team closely monitors his response to the interventions. Over the next 48 hours, there is a noticeable improvement in his cognitive function. The patient starts to engage more in conversations, although intermittently, and demonstrates a reduced frequency of asterixis. This suggests a positive response to the lactulose therapy, as ammonia levels decrease to 65 µmol/L. However, despite these improvements, the patient's ascites appears to have increased, and he reports feeling more bloated and uncomfortable. The healthcare team notes that his abdominal girth has expanded by 2 cm since the last measurement, indicating a need for further adjustment of diuretic therapy.
In light of the increasing ascites, repeat laboratory tests reveal a sodium level of 130 mmol/L, suggesting mild hyponatremia likely secondary to the aggressive diuretic management. The healthcare team decides to adjust the diuretic regimen, balancing the need to manage fluid overload while avoiding further electrolyte disturbances. The patient's platelet count remains low at 75,000/mm³, which maintains the risk for bleeding. Given the persistent thrombocytopenia and the presence of esophageal varices, the team prioritizes an urgent endoscopic evaluation to assess the severity of the varices and perform banding if necessary.
Meanwhile, the patient's liver function tests show a slight worsening, with an increase in bilirubin levels and further elevation of liver enzymes, suggesting ongoing hepatic deterioration. The healthcare team discusses the possibility of referring the patient for a more comprehensive evaluation for liver transplantation, given the progressive nature of his liver disease. This step is crucial to ensure timely intervention and improve long-term outcomes, as the patient's condition remains precarious. The team remains vigilant, ready to address any new complications that may arise, while continuing to optimize current treatment strategies.
Section 4
As the patient continues to receive care, the healthcare team observes a change in his status, marked by the emergence of new complications. Over the next 24 hours, the patient becomes increasingly lethargic, with a noticeable decline in his level of alertness compared to the previous day. Despite the initial improvement in cognitive function, he now struggles to stay awake during conversations and exhibits frequent lapses in attention. Vital signs reveal a blood pressure of 90/60 mmHg and a heart rate of 110 beats per minute, indicating a possible hypovolemic state related to the adjusted diuretic therapy. Furthermore, the patient's respiratory rate has increased to 24 breaths per minute, suggesting a potential compensatory response to metabolic disturbances.
Laboratory results reveal a concerning drop in serum sodium to 127 mmol/L, exacerbating the patient's hyponatremia and contributing to his altered mental status. Additionally, his serum creatinine has risen to 1.8 mg/dL, indicating a decline in renal function, likely due to hepatorenal syndrome as a complication of his worsening liver failure. The healthcare team recognizes the urgent need to reassess the patient's fluid and electrolyte management, aiming to stabilize his hemodynamic status while minimizing further renal impairment. In response, the team decides to cautiously reduce the diuretic dosage and considers initiating albumin infusion to support circulatory function and improve renal perfusion.
Given the patient's deteriorating condition, the team also prioritizes accelerating the evaluation process for liver transplantation. This step is crucial as the patient's current trajectory suggests rapidly advancing liver disease with multi-organ involvement. The healthcare team engages in a multidisciplinary discussion to ensure all necessary assessments and consultations are expedited, optimizing the patient's eligibility for transplantation. Throughout this critical phase, the team remains vigilant, prepared to address any additional complications that may arise and to adjust the treatment plan as needed to support the patient's recovery and long-term prognosis.
Section 5
Over the next 12 hours, the patient's condition evolves, revealing new complications that demand further clinical attention. Despite the healthcare team's efforts to stabilize his hemodynamic status, the patient develops signs of ascites, characterized by increased abdominal girth and discomfort. His respiratory rate remains elevated at 26 breaths per minute, and he reports difficulty breathing when lying flat, indicative of potential fluid accumulation impacting respiratory function. The team notes a mild increase in jaundice, with bilirubin levels rising to 5.2 mg/dL, suggesting worsening liver function and an impaired ability to process and excrete bilirubin.
Further laboratory results reveal a coagulation profile with an international normalized ratio (INR) of 2.1, indicating a decline in the liver's synthetic function and raising concerns about the increased risk of bleeding. This finding necessitates a careful re-evaluation of the patient's anticoagulation status, especially given the potential need for invasive procedures related to the liver transplant evaluation. In parallel, the patient's hyponatremia remains a challenge, with serum sodium levels persistently low at 126 mmol/L despite adjustments in fluid management, contributing to his ongoing lethargy and cognitive impairment.
In response to these developments, the healthcare team intensifies their focus on managing the patient's fluid balance and optimizing his candidacy for liver transplantation. They initiate a low-sodium diet and carefully monitor fluid intake to prevent further dilutional hyponatremia, while planning for therapeutic paracentesis to relieve abdominal discomfort and improve respiratory function. The team also explores the possibility of using vasopressin receptor antagonists to address the patient's hyponatremia while continuing to evaluate his overall stability and readiness for transplant listing. Through close monitoring and timely interventions, the team aims to navigate these complex challenges, ensuring the patient's best chance for recovery and successful transplantation.